Bioorganic & Medicinal Chemistry 1999-09-01

Structure-activity relationship of HIV-1 protease inhibitors containing alpha-hydroxy-beta-amino acids. Detailed study of P1 site.

E Takashiro, I Hayakawa, T Nitta, A Kasuya, S Miyamoto, Y Ozawa, R Yagi, I Yamamoto, T Shibayama, A Nakagawa, Y Yabe

文献索引:Bioorg. Med. Chem. 7(9) , 2063-72, (1999)

全文:HTML全文

摘要

The structure-activity relationship of HIV-1 protease (HIV-1 PR) inhibitors containing alpha-hydroxy-beta-amino acids is discussed. We demonstrated that substituent groups on the P1 aromatic rings of the inhibitors exert significant influence on their biological activity. Inhibitors bearing an alkyl or a fluorine atom at the meta and para position on their P1 benzene ring were found to be good inhibitors. We also discovered that the substitution positions of the P2 benzamides were crucial for good antiviral potency. In this study, inhibitor 48 was the most potent [IC90 (CEM/HIV-1 IIIB) 27 nM] and showed good pharmacokinetics in rats.


相关化合物

  • 5-氟-2-甲基苯甲酸

相关文献:

Multkilogram Scale-Up of a Reductive Alkylation Route to a Novel PARP Inhibitor. Gillmore AT, et al.

[Org. Process Res. Dev. 16(12) , 2063-72, (1999)]

Design of HIV-1 integrase inhibitors targeting the catalytic domain as well as its interaction with LEDGF/p75: a scaffold hopping approach using salicylate and catechol groups.

2011-08-15

[Bioorg. Med. Chem. 19 , 4935, (2011)]

更多文献...